In a bid to prioritise more human-relevant models, the US Food and Drug Administration (FDA) has enforced a plan to phase out animal testing for monoclonal antibodies (mAbs) in the preclinical stage, ...

Around 348 B.C., Aristotle took a two-year trip to the eastern Aegean island of Lesbos to study animals in a lagoon. Along with observing the creatures in their natural habitat and surmising, among ...

Every year, millions of animals are used in laboratories, and for many people, the image is immediate and uncomfortable: ...

Stem Pharm, a Madison biotech startup, is using lab-created 3D "organoids" to develop a treatment for Alzheimer's disease. In April, the FDA and NIH announced plans to incentivize so-called "new ...

Katie has a PhD in maths, specializing in the intersection of dynamical systems and number theory. She reports on topics from maths and history to society and animals. Katie has a PhD in maths, ...

In a Policy Forum, Chad Nelson and colleagues highlight the efforts of the U.S. Food and Drug Administration (FDA) in advancing alternative methods to reduce animal testing for regulatory use. Animal ...

Key Takeaways. Draft guidance targets reduction/elimination of nonhuman primate testing for monoclonal antibodies, signaling higher regulatory receptivity to alternative nonclinic ...

Drug developers will be able to use alternatives to animal testing and possibly get new products to market faster under draft guidance issued Wednesday by the FDA. In a press release, officials said ...

Other countries, like the U.K, the United States and the European Union have all dedicated funding and detailed roadmaps to ...